Save your place

Sign in to WhoBought

Please try again later.

Catalyst Biosciences, Inc. (CBIO) institutional ownership

Latest close $15.05 Jul 20, 2026
Market cap$234M 52-week range SectorHealthcare
Funds holding · Q1 2026
53
reported CBIO position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
32 buyers · 21 sellers

Catalyst Biosciences, Inc. (CBIO) price and institutional activity

Dates

Q1 2026

$0 bought by 32 investors
Balyasny Asset Management L.P.Tang Capital Management LLC +30 more
$0 sold by 21 investors
VanguardAdar1 Capital Management, LLC +19 more
Sign in to see who bought
Bought Sold Totals per quarter; hover a bar for the names.

Catalyst Biosciences, Inc. (CBIO) institutional activity · 32

Investor Type Est. change Change Δ Own Date
Balyasny Asset Management L.P. · Added
Change +1.4M Date Q1 2026
Balyasny Asset Management L.P. Added· Q1 2026 +1.4M Q1 2026
Tang Capital Management LLC · Added
Change +288K Date Q1 2026
Tang Capital Management LLC Added· Q1 2026 +288K Q1 2026
Millennium Management LLC · Added
Change +262K Date Q1 2026
Millennium Management LLC Added· Q1 2026 +262K Q1 2026
Goldman Sachs Group Inc · Added
Change +203K Date Q1 2026
Goldman Sachs Group Inc Added· Q1 2026 +203K Q1 2026
Marshall Wace, LLP · Added
Change +179K Date Q1 2026
Marshall Wace, LLP Added· Q1 2026 +179K Q1 2026
Susquehanna International Group, LLP · Added
Change +157K Date Q1 2026
Susquehanna International Group, LLP Added· Q1 2026 +157K Q1 2026
Exome Asset Management LLC · New
Change +153K Date Q1 2026
Exome Asset Management LLC New· Q1 2026 +153K Q1 2026
Jennison Associates LLC · New
Change +153K Date Q1 2026
Jennison Associates LLC New· Q1 2026 +153K Q1 2026
Opaleye Management Inc. · Added
Change +134K Date Q1 2026
Opaleye Management Inc. Added· Q1 2026 +134K Q1 2026
Silverarc Capital Management, LLC · New
Change +130K Date Q1 2026
Silverarc Capital Management, LLC New· Q1 2026 +130K Q1 2026
Hudson Bay Capital Management LP · New
Change +89K Date Q1 2026
Hudson Bay Capital Management LP New· Q1 2026 +89K Q1 2026
UBS Group AG · Added
Change +76K Date Q1 2026
UBS Group AG Added· Q1 2026 +76K Q1 2026
Barclays PLC · New
Change +30K Date Q1 2026
Barclays PLC New· Q1 2026 +30K Q1 2026
State Street · Added
Change +27K Date Q1 2026
State Street Added· Q1 2026 +27K Q1 2026
Lighthouse Investment Partners, LLC · New
Change +25K Date Q1 2026
Lighthouse Investment Partners, LLC New· Q1 2026 +25K Q1 2026
Data through Q1 2026 · filed Jun 2, 2026
15 of 32

Famous investor activity in Catalyst Biosciences, Inc. (CBIO)

Catalyst Biosciences, Inc. (CBIO) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Fairmount Funds Management LLC · Director Buy +$12M
Price $14.50 Qty +853K Owned 3.6M ΔOwn +31.1% Trade date Jul 16, 2026 Filed date Jul 20, 2026
Fairmount Funds Management LLC Director Buy $14.50 +853K +$12M 3.6M +31.1% Jul 16, 2026 Jul 20, 2026
Fairmount Funds Management LLC · Director Other Form 4 event (P, derivative) $7.6M
Price $14.50 Qty 526K Owned 2.3M Trade date Jul 16, 2026 Filed date Jul 20, 2026
Fairmount Funds Management LLC Director Other Form 4 event (P, derivative) $14.50 526K $7.6M 2.3M Jul 16, 2026 Jul 20, 2026
Lynch Ryan · Officer Sell −$8K
Price $17.99 Qty −465 Owned 14K ΔOwn −3.2% Trade date Jun 22, 2026 Filed date Jun 23, 2026
Lynch Ryan Officer Sell $17.99 −465 −$8K 14K −3.2% Jun 22, 2026 Jun 23, 2026
Pinkas Jan · Officer Sell −$23K
Price $17.99 Qty −1K Owned 22K ΔOwn −5.5% Trade date Jun 22, 2026 Filed date Jun 23, 2026
Pinkas Jan Officer Sell $17.99 −1K −$23K 22K −5.5% Jun 22, 2026 Jun 23, 2026
Scalzo Richard William · Officer Sell −$20K
Price $17.99 Qty −1K Owned 20K ΔOwn −5.2% Trade date Jun 22, 2026 Filed date Jun 23, 2026
Scalzo Richard William Officer Sell $17.99 −1K −$20K 20K −5.2% Jun 22, 2026 Jun 23, 2026
Bispham Barbara Harlin · Officer Sell −$22K
Price $17.99 Qty −1K Owned 19K ΔOwn −5.9% Trade date Jun 22, 2026 Filed date Jun 23, 2026
Bispham Barbara Harlin Officer Sell $17.99 −1K −$22K 19K −5.9% Jun 22, 2026 Jun 23, 2026
IM Ellie Eunkyung · Officer Sell −$22K
Price $17.99 Qty −1K Owned 22K ΔOwn −5.2% Trade date Jun 22, 2026 Filed date Jun 23, 2026
IM Ellie Eunkyung Officer Sell $17.99 −1K −$22K 22K −5.2% Jun 22, 2026 Jun 23, 2026
McNeill Jonathan · Officer Sell −$370K
Price $17.99 Qty −21K Owned 139K ΔOwn −12.9% Trade date Jun 22, 2026 Filed date Jun 23, 2026
McNeill Jonathan Officer Sell $17.99 −21K −$370K 139K −12.9% Jun 22, 2026 Jun 23, 2026
Brumm Joshua T. · Director Sell −$761K
Price $17.99 Qty −42K Owned 281K ΔOwn −13.1% Trade date Jun 22, 2026 Filed date Jun 23, 2026
Brumm Joshua T. Director Sell $17.99 −42K −$761K 281K −13.1% Jun 22, 2026 Jun 23, 2026
Violin Jonathan · Director Grant (A) 11K
Owned 11K Trade date Jun 2, 2026 Filed date Jun 3, 2026
Violin Jonathan Director Grant (A) 11K 11K Jun 2, 2026 Jun 3, 2026
Lubner David Charles · Director Grant (A) 11K
Owned 11K Trade date Jun 2, 2026 Filed date Jun 3, 2026
Lubner David Charles Director Grant (A) 11K 11K Jun 2, 2026 Jun 3, 2026
Balcom Alexandra · Director Grant (A) 11K
Owned 11K Trade date Jun 2, 2026 Filed date Jun 3, 2026
Balcom Alexandra Director Grant (A) 11K 11K Jun 2, 2026 Jun 3, 2026
Moran Susan · Director Grant (A) 11K
Owned 11K Trade date Jun 2, 2026 Filed date Jun 3, 2026
Moran Susan Director Grant (A) 11K 11K Jun 2, 2026 Jun 3, 2026
Fairmount Funds Management LLC · Director Grant (A) 11K
Owned 11K Trade date Jun 2, 2026 Filed date Jun 3, 2026
Fairmount Funds Management LLC Director Grant (A) 11K 11K Jun 2, 2026 Jun 3, 2026
Pinkas Jan · Officer 3 operations 93K
Owned 70K Trade date Dec 15, 2025 Filed date Dec 17, 2025
Pinkas Jan Officer 3 operations 93K 70K Dec 15, 2025 Dec 17, 2025
15 of 26
15 of 26 Sign in to continue to older insider transactions.

Catalyst Biosciences, Inc. (CBIO) activist and large shareholders

What are Schedules 13D and 13G?

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Artal International S.c.a. 8.6M
% of shares outstanding 13.3% Filing date Feb 9, 2024
Artal International S.c.a. 8.6M 13.3% Feb 9, 2024
Adage Capital Management, L.P. 5.1M
% of shares outstanding 7.9% Filing date Nov 4, 2024
Adage Capital Management, L.P. 5.1M 7.9% Nov 4, 2024
Logos Global Management LP 5.0M
% of shares outstanding 7.8% Filing date Nov 27, 2024
Logos Global Management LP 5.0M 7.8% Nov 27, 2024
Biotechnology Value Fund L P 5.0M
% of shares outstanding 7.7% Filing date Jan 29, 2024
Biotechnology Value Fund L P 5.0M 7.7% Jan 29, 2024
New Enterprise Associates 10 L P 4.7M
% of shares outstanding 7.3% Filing date Feb 12, 2024
New Enterprise Associates 10 L P 4.7M 7.3% Feb 12, 2024
Balyasny Asset Management L.P. 1.5M
% of shares outstanding 5.5% Filing date May 15, 2026
Balyasny Asset Management L.P. 1.5M 5.5% May 15, 2026
Tang Capital Management, LLC 1.2M
% of shares outstanding 4.2% Filing date May 15, 2026
Tang Capital Management, LLC 1.2M 4.2% May 15, 2026
Invus Global Management, LLC 2.0M
% of shares outstanding 3.0% Filing date Nov 12, 2024
Invus Global Management, LLC 2.0M 3.0% Nov 12, 2024
8 of 10

Catalyst Biosciences, Inc. (CBIO) ownership FAQ

Who owns CBIO?

53 reporting institutions disclosed CBIO position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.